PHP60 - Pharmaceutical Industry\\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

C Dintsios,S Schlenkrich

doi:10.1016/j.jval.2016.09.598

PHP60 - Pharmaceutical Industry\\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

C Dintsios, S Schlenkrich

Open Access

https://doi.org/10.1016/j.jval.2016.09.598

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Oct 31, 2016
License type: publisher-specific-oa

Affiliation: Heinrich Heine University Düsseldorf, Zittau/Görlitz University of Applied Sciences

#Drugs In Germany #Federal Joint Committee + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

PHP60 - Pharmaceutical Industry\\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

Full Text